gefitinib has been researched along with acetonitrile in 2 studies
| Studies (gefitinib) | Trials (gefitinib) | Recent Studies (post-2010) (gefitinib) | Studies (acetonitrile) | Trials (acetonitrile) | Recent Studies (post-2010) (acetonitrile) |
|---|---|---|---|---|---|
| 5,231 | 566 | 2,919 | 3,724 | 15 | 1,703 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beijnen, JH; Durmus, S; Schellens, JH; Schinkel, AH; Sparidans, RW | 1 |
| Chen, X; Feng, W; Guan, S; Huang, M; Liu, S; Wang, F; Wang, X; Xin, S; Zhang, L; Zhou, S; Zhu, X; Zhuang, W | 1 |
2 other study(ies) available for gefitinib and acetonitrile
| Article | Year |
|---|---|
Liquid chromatography-tandem mass spectrometric assay for the PARP inhibitor rucaparib in plasma.
Topics: Acetonitriles; Animals; Area Under Curve; Calibration; Chromatography, Liquid; Edetic Acid; Female; Gefitinib; Indoles; Mice; Poly(ADP-ribose) Polymerase Inhibitors; Protein Kinase Inhibitors; Quality Control; Quinazolines; Reproducibility of Results; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry | 2014 |
Development and validation of a sensitive LC-MS/MS method for determination of gefitinib and its major metabolites in human plasma and its application in non-small cell lung cancer patients.
Topics: Acetonitriles; Calibration; Carcinoma, Non-Small-Cell Lung; Chromatography, Liquid; Formates; Gefitinib; Humans; Lung Neoplasms; Plasma; Reproducibility of Results; Tandem Mass Spectrometry | 2019 |